Radiation Oncology/Therapy: Page 431

PET firm CTI reports strong year-end results
By AuntMinnie.com staff writers
PET provider CTI Molecular Imaging reported fiscal fourth-quarter revenues of $86.5 million, up 15% from the $75.5 million in sales posted in the same period last year.
November 19, 2002
Nucletron product gets FDA 510(k) clearance
By AuntMinnie.com staff writers
Dutch radiation therapy firm Nucletron has gained U.S. Food and Drug Administration 510(k) clearance for its Spot Pro 3-D ultrasound planning system for all seed-implant techniques.
November 19, 2002
Nomos to appeal in patent suit against Zmed
By AuntMinnie.com staff writers
Intensity modulated radiation therapy (IMRT) provider Nomos has appealed an adverse court ruling in its patent infringement case against Zmed, an Ashland, MA-based medical technology firm.
November 19, 2002
US Oncology adds to PET network
By AuntMinnie.com staff writers
US Oncology cancer centers in Texas and Illinois have added PET imaging capabilities.
November 17, 2002
Elekta inks MedAssets deal
By AuntMinnie.com staff writers
Swedish radiation therapy firm Elekta said it has become the preferred radiosurgery provider for group purchasing organization MedAssets HSCA. The contract covers the Stockholm firm's Leksell gamma knife and Leksell stereotactic system.
November 13, 2002
Neoprobe’s Q3 revenues sag
By AuntMinnie.com staff writers
Gamma-probe developer Neoprobe reported third-quarter revenues of $920,000, down 51.5% compared with the $1.9 million in sales posted in the third quarter last year. The company attributed the loss to a decline in demand for its gamma-detection devices by its primary marketing partner, Ethicon Endo-Surgery.
November 12, 2002
Accuray inks Asian distributor agreement
By AuntMinnie.com staff writers
Accuray has signed a distributor agreement with President Medical Technologies of Taiwan.
November 11, 2002
CMS to maintain PET payment rates
By Kate Madden Yee
PET proponents are rejoicing at the news that the Centers for Medicare and Medicaid Services (CMS) will retain 2002 outpatient reimbursement rates for FDG-PET procedures next year. CMS had been proposing a 42% cut in the rate for oncology PET procedures and a 9% cut in cardiac PET payments for its 2003 outpatient payment schedule.
November 7, 2002
Cardinal uncovers questionable Syncor payments
By AuntMinnie.com staff writers
Healthcare giant Cardinal Health has uncovered evidence of "questionable payments" at Syncor International, the Woodland Hills, CA-based radiopharmaceutical company that Cardinal has proposed to acquire.
November 6, 2002
Mentor to buy ProstaSeed maker Mills
By AuntMinnie.com staff writers
Mentor of Santa Barbara, CA, has reached an agreement to acquire Mills Biopharmaceuticals of Oklahoma City, OK.
November 5, 2002
MDS Nordion medical isotope reactor restarted
By AuntMinnie.com staff writers
Canadian isotope manufacturer MDS Nordion has received Canadian Nuclear Safety Commission (CNSC) authorization to restart low-power commissioning of its Maple 1 reactor at Chalk River, ON, near its Ottawa headquarters.
October 28, 2002
Cytogen implements reverse stock split
By AuntMinnie.com staff writers
Biopharmaceutical vendor Cytogen has implemented a 1-for-10 reverse stock split.
October 27, 2002
Previous Page
Page 431 of 464
Next Page